Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges.
作者信息
Musuamba Flora T, Bursi Roberta, Manolis Efthymios, Karlsson Kristin, Kulesza Alexander, Courcelles Eulalie, Boissel Jean-Pierre, Lesage Raphaëlle, Crozatier Cécile, Voisin Emmanuelle M, Rousseau Cécile F, Marchal Thierry, Alessandrello Rossana, Geris Liesbet
机构信息
EMA Modelling and Simulation Working Party, Amsterdam, The Netherlands.
Federal Agency for Medicines and Health Products, Brussels, Belgium.
出版信息
CPT Pharmacometrics Syst Pharmacol. 2020 Apr;9(4):195-197. doi: 10.1002/psp4.12504. Epub 2020 Apr 1.
Abstract
摘要
相似文献
1
Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges.在药物研发中验证和确认定量系统药理学及计算机模拟模型：当前需求、差距与挑战
CPT Pharmacometrics Syst Pharmacol. 2020 Apr;9(4):195-197. doi: 10.1002/psp4.12504. Epub 2020 Apr 1.
2
Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?生理药代动力学（PBPK）模型在药物计量学和系统药理学中处于什么地位？
CPT Pharmacometrics Syst Pharmacol. 2020 Feb;9(2):75-76. doi: 10.1002/psp4.12493. Epub 2020 Jan 26.
3
FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspective.FDA-Industry 科学交流会议报告：评估定量系统药理学模型在临床药物开发中的应用：会议报告、挑战/差距总结及未来展望。
AAPS J. 2021 Apr 30;23(3):60. doi: 10.1208/s12248-021-00585-x.
4
The clinical utility of pharmacometric models.药代动力学模型的临床应用。
Br J Clin Pharmacol. 2018 Jul;84(7):1413-1414. doi: 10.1111/bcp.13603. Epub 2018 May 2.
5
A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development.定量系统药理学在临床药物研发中的应用展望
CPT Pharmacometrics Syst Pharmacol. 2020 Dec;9(12):675-677. doi: 10.1002/psp4.12567. Epub 2020 Nov 7.
6
What Can Mathematics Do for Drug Development?数学在药物研发中能发挥什么作用？
Bull Math Biol. 2019 Sep;81(9):3421-3424. doi: 10.1007/s11538-019-00632-x.
7
Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.药物研发中的转化定量系统药理学：从现状到良好实践。
AAPS J. 2019 Jun 3;21(4):72. doi: 10.1208/s12248-019-0339-5.
8
Pharmacometrics and systems pharmacology for metabolic bone diseases.代谢性骨病的药物代谢动力学和系统药理学。
Br J Clin Pharmacol. 2019 Jun;85(6):1136-1146. doi: 10.1111/bcp.13881. Epub 2019 Feb 28.
9
Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?系统药理学在药物发现和开发中的应用：范式转变还是昙花一现？
Clin Pharmacol Ther. 2013 May;93(5):379-81. doi: 10.1038/clpt.2013.40.
10
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.定量系统神经药理学在神经科学药物研发中的应用：现状、机遇与挑战。
CPT Pharmacometrics Syst Pharmacol. 2020 Jan;9(1):5-20. doi: 10.1002/psp4.12478. Epub 2019 Nov 24.
引用本文的文献
1
Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges.生物类似药的创新制剂策略：聚焦无缓冲系统、安全性、监管一致性及知识产权挑战的趋势
Pharmaceuticals (Basel). 2025 Jun 17;18(6):908. doi: 10.3390/ph18060908.
2
Recommendations for the Application of Sex and Gender Medicine in Preclinical, Epidemiological and Clinical Research.性与性别医学在临床前、流行病学及临床研究中的应用建议
J Pers Med. 2024 Aug 27;14(9):908. doi: 10.3390/jpm14090908.
3
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report.生理药代动力学模型参数化：研讨会总结报告。
Mol Pharm. 2024 Aug 5;21(8):3697-3731. doi: 10.1021/acs.molpharmaceut.4c00526. Epub 2024 Jun 30.
4
Advancing cancer drug development with mechanistic mathematical modeling: bridging the gap between theory and practice.运用机制数学建模推进癌症药物研发：弥合理论与实践之间的差距。
J Pharmacokinet Pharmacodyn. 2024 Dec;51(6):581-604. doi: 10.1007/s10928-024-09930-x. Epub 2024 Jun 21.
5
Artificial Intelligence and Anticancer Drug Development-Keep a Cool Head.人工智能与抗癌药物研发——保持冷静头脑
Pharmaceutics. 2024 Jan 31;16(2):211. doi: 10.3390/pharmaceutics16020211.
6
Development of bispecific T cell engagers: harnessing quantitative systems pharmacology.双特异性 T 细胞衔接器的开发：利用定量系统药理学。
Trends Pharmacol Sci. 2023 Dec;44(12):880-890. doi: 10.1016/j.tips.2023.09.009. Epub 2023 Oct 17.
7
In Silico Clinical Trials: Is It Possible?计算机临床试验：是否可行？
Methods Mol Biol. 2024;2716:51-99. doi: 10.1007/978-1-0716-3449-3_4.
8
Empirical methods for the validation of time-to-event mathematical models taking into account uncertainty and variability: application to EGFR + lung adenocarcinoma.考虑不确定性和变异性的时间事件数学模型验证的经验方法：在 EGFR+肺腺癌中的应用。
BMC Bioinformatics. 2023 Sep 4;24(1):331. doi: 10.1186/s12859-023-05430-w.
9
VeVaPy, a Python Platform for Efficient Verification and Validation of Systems Biology Models with Demonstrations Using Hypothalamic-Pituitary-Adrenal Axis Models.VeVaPy，一个用于系统生物学模型高效验证与确认的Python平台，并使用下丘脑-垂体-肾上腺轴模型进行演示。
Entropy (Basel). 2022 Nov 29;24(12):1747. doi: 10.3390/e24121747.
10
Understanding virtual patients efficiently and rigorously by combining machine learning with dynamical modelling.通过将机器学习与动态建模相结合，有效地、严格地理解虚拟患者。
J Pharmacokinet Pharmacodyn. 2022 Feb;49(1):117-131. doi: 10.1007/s10928-021-09798-1. Epub 2022 Jan 5.
本文引用的文献
1
Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and Simulation.考虑在模型指导药物开发中的可信度评估框架：在生理基于药代动力学建模和模拟中的潜在应用。
CPT Pharmacometrics Syst Pharmacol. 2020 Jan;9(1):21-28. doi: 10.1002/psp4.12479. Epub 2019 Nov 10.
2
The US Food and Drug Administration's Model-Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact.美国食品药品监督管理局的模型辅助药物研发配对会议试点项目：早期经验与影响
Clin Pharmacol Ther. 2019 Jul;106(1):74-78. doi: 10.1002/cpt.1457. Epub 2019 May 13.
3
In silico models in drug development: where we are.在药物研发中的计算机模型：我们所处的位置。
Curr Opin Pharmacol. 2018 Oct;42:111-121. doi: 10.1016/j.coph.2018.08.007. Epub 2018 Sep 8.
Zotero 插件